Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Dynamic Markets Need Dynamic Pricing: Roche Explores Differential Pricing Strategies In Emerging Markets

Feb 16 2012

• By Brian Yang

Related Content

Egyptian Drug Price Reform: New Trade Barrier Or Demand Driver?

Oct 28 2010

MNCs Need China-Oriented Oncology Strategy Mixed With Pricing Know-how

Dec 14 2010

BMS Benefits From Focused Strategy, Novartis Looks To Vaccines; Abbott Tries To Educate U.S. Investors: Emerging Markets Earnings Roundup (Part 2)

May 06 2011

Insider Analysis From Easton Associates: Are Patient Assistance Programs The Silver Bullet To Meet Affordability Challenges In China?

Sep 06 2011

Will Innovation Replace Branded Generics As Dominant Strategy For Big Pharma In Emerging Markets? (Part 2 of 2)

Mar 07 2011

Related Companies

Roche Holding AG

Merck & Co., Inc.

Sanofi

GSK plc

Pfizer Inc.

Bristol Myers Squibb Company

Emcure Pharmaceuticals Pvt Ltd.

Novartis AG

Novartis AG

Additional Topics

Asia Pacific Middle East and Africa Pricing Strategies Emerging Markets BioPharmaceutical

More from Focus On Asia

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window